|
1003
|
3198
|
3vkgA |
X-ray structure of an mtbd truncation mutant of dynein motor domain |
|
899
|
3218
|
3vkhA |
X-ray structure of a functional full-length dynein motor domain |
|
807
|
2695
|
4ai6A |
Dynein motor domain - adp complex |
|
804
|
2695
|
4akgA |
Dynein motor domain - atp complex |
|
798
|
2695
|
4akhA |
Dynein motor domain - amppnp complex |
|
798
|
2695
|
4akiA |
Dynein motor domain - luac derivative |
|
16
|
114
|
1enwA |
Elongation factor tfiis domain ii |
|
28
|
134
|
4by7X |
Elongating rna polymerase ii-bye1 tld complex |
|
28
|
192
|
4bbsM |
Structure of an initially transcribing rna polymerase ii-tfiib complex |
|
33
|
164
|
3po3S |
Arrested rna polymerase ii reactivation intermediate |
|
60
|
263
|
2w2hA |
Structural basis of transcription activation by the cyclin t1-tat-tar rna complex from eiav |
|
18
|
163
|
3gtmS |
Co-complex of backtracked rna polymerase ii with tfiis |
|
21
|
134
|
4by1X |
Elongating rna polymerase ii-bye1 tld complex soaked with ampcpp |
|
82
|
201
|
1d3uB |
Tata-binding protein/transcription factor (ii)b/bre+tata-box complex from pyrococcus woesei |
|
65
|
193
|
1aisB |
Tata-binding protein/transcription factor (ii)b/tata-box complex from pyrococcus woesei |
|
75
|
207
|
1c9bA |
Crystal structure of a human tbp core domain-human tfiib core domain complex bound to an extended, modified adenoviral major late promoter (admlp) |
|
66
|
204
|
1volA |
Tfiib (human core domain)/tbp (a.thaliana)/tata element ternary complex |
|
105
|
343
|
4rocA |
Human tfiib-related factor 2 (brf2) and tbp bound to u6#2 promoter |
|
99
|
342
|
4rodA |
Human tfiib-related factor 2 (brf2) and tbp bound to trnau1 promoter |
|
94
|
258
|
5lmkB |
Structure of phopsho-cdk2-cyclin a in complex with an atp-competitive inhibitor |
|
98
|
264
|
5lqfB |
Cdk1/cyclinb1/cks2 in complex with nu6102 |
|
90
|
270
|
5l2wB |
The x-ray co-crystal structure of human cdk2/cycline and dinaciclib. |
|
94
|
257
|
5if1B |
Crystal structure apo cdk2/cyclin a |
|
93
|
266
|
5i5zB |
Cdk8-cycc in complex with 8-(1-methyl-2,2-dioxo-2,3-dihydro-1h-2l6-benzo[c]isothiazol-5-yl)-[1,6]naphthyridine-2-carboxylic acid methylamide |
|
100
|
267
|
5icpB |
Cdk8-cycc in complex with [(s)-2-(4-chloro-phenyl)-pyrrolidin-1-yl]-(5-methyl-imidazo[5,1-b][1,3,4]thiadiazol-2-yl)-methanone |
|
93
|
268
|
5idpB |
Cdk8-cycc in complex with (3-amino-1h-indazol-5-yl)-[(s)-2-(4-fluoro-phenyl)-piperidin-1-yl]-methanone |
|
92
|
267
|
5hvyB |
Cdk8/cycc in complex with compound 20 |
|
93
|
266
|
5hbeB |
Cdk8-cycc in complex with 8-[3-chloro-5-(1-methyl-2,2-dioxo-2, 3-dihydro-1h-2l6-benzo[c]isothiazol-5-yl)-pyridin- 4-yl]-1-oxa-3,8-diaza-spiro[4.5]decan-2-one |
|
90
|
241
|
5acbA |
Crystal structure of the human cdk12-cyclink complex |
|
335
|
1059
|
4hntA |
Crystal structure of f403a mutant of s. aureus pyruvate carboxylase |
|
95
|
260
|
4cfxB |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
97
|
262
|
4cfuB |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
97
|
258
|
5cyiB |
Cdk2/cyclin a covalent complex with 6-(cyclohexylmethoxy)-n-(4-(vinylsulfonyl)phenyl)-9h-purin-2-amine (nu6300) |
|
104
|
268
|
5ceiB |
Crystal structure of cdk8:cyclin c complex with compound 22 |
|
91
|
266
|
5bnjB |
Cdk8/cycc in complex with 8-{3-chloro-5-[4-(1-methyl-1h-pyrazol-4-yl)-phenyl]-pyridin- 4-yl}-2,8-diaza-spiro[4.5]decan-1-one |
|
349
|
1144
|
4hnvA |
Crystal structure of r54e mutant of s. aureus pyruvate carboxylase |
|
57
|
206
|
4zgdB |
Mutant r157a of fe-type nitrile hydratase from comamonas testosteroni ni1 |
|
52
|
206
|
4zgeB |
Double mutant h80w/h81w of fe-type nitrile hydratase from comamonas testosteroni ni1 |
|
334
|
1059
|
4hnuA |
Crystal structure of k442e mutant of s. aureus pyruvate carboxylase |
|
103
|
273
|
4z6yA |
Structure of the tbc1d7-tsc1 complex |
|
55
|
206
|
4zgjB |
Double mutant h80a/h81a of fe-type nitrile hydratase from comamonas testosteroni ni1 |
|
99
|
267
|
4f7sB |
Crystal structure of human cdk8/cycc in the dmg-in conformation |
|
97
|
268
|
4f7jB |
Crystal structure of human cdk8/cycc in complex with compound 3 (1-[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-3-(2-hydroxyethyl)urea) |
|
94
|
268
|
4f7nB |
Crystal structure of human cdk8/cycc in complex with compound 11 (1-[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-3-(5-hydroxypentyl)urea) |
|
100
|
266
|
4f6sB |
Crystal structure of human cdk8/cycc in complex with compound 7 (1-[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]urea) |
|
226
|
638
|
4eljA |
Crystal structure of the inactive retinoblastoma protein phosphorylated at t373 |
|
93
|
266
|
4f70B |
Crystal structure of human cdk8/cycc in complex with compound 4 (1-[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-3-[2-(morpholin-4-yl)ethyl]urea) |
|
100
|
267
|
4f6wB |
Crystal structure of human cdk8/cycc in complex with compound 1 (n-[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-4-[2-({[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]carbamoyl}amino)ethyl]piperazine-1-carboxamide) |
|
85
|
266
|
4f7lB |
Crystal structure of human cdk8/cycc in complex with compound 2 (tert-butyl [3-({[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]carbamoyl}amino)propyl]carbamate) |
|
98
|
267
|
4f6uB |
Crystal structure of human cdk8/cycc in complex with compound 5 (1-[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-3-[3-(morpholin-4-yl)propyl]urea) |
